Results 251 to 260 of about 274,774 (268)
Some of the next articles are maybe not open access.

Plasmid DNA vaccination

Microbes and Infection, 2005
Plasmid DNA vaccination against tuberculosis is a very powerful and easy method for the induction of strong humoral responses, CD4+ mediated secretion of Th1 cytokines and CD8+ mediated CTL activity in mice. Tuberculosis DNA vaccines have not been assessed so far in humans, and clinical trials with DNA in general have been somewhat disappointing ...
openaire   +2 more sources

Tuberculosis DNA Vaccines

Scandinavian Journal of Infectious Diseases, 2001
DNA vaccines have been the subject of intense investigation for the past 10 y, during which time several tuberculosis (TB) DNA vaccines have been shown to confer protective immunity in animal models. So far, proof of principle for priming of immune responses by a naked DNA vaccine (malaria) has been demonstrated in humans, but potency remains a ...
openaire   +2 more sources

Veterinary DNA Vaccines

2003
Vaccination has relied, in general, on two technologies for the production of antigenic material suitable for the generation of a protective immune response; live infectious agents and inactivated or subunit vaccine preparations. Live infectious agents generally are most efficacious, but there is always a risk factor when using this type of vaccine ...
S, van Drunen Littel-van den Hurk   +2 more
openaire   +2 more sources

DNA Vaccines and Intradermal Vaccination by DNA Tattooing

2010
Over the past two decades, DNA vaccination has been developed as a method for the induction of immune responses. However, in spite of high expectations based on their efficacy in preclinical models, immunogenicity of first generation DNA vaccines in clinical trials was shown to be poor, and no DNA vaccines have yet been licensed for human use.
K, Oosterhuis   +3 more
openaire   +2 more sources

Plasmid DNA Vaccines

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2001
Genes that code for the production of protein antigens have been cloned and recombined with plasmids. Gene-plasmid constructs have been amplified in a bacterial host, purified and administered to a mammalian host. The gene is expressed in the host and the antigen that is produced induces an immune response.
openaire   +2 more sources

DNA Vaccines

International Journal of Pharmaceutical Medicine, 2005
Compared with conventional approaches, DNA vaccine technology is a relatively new methodology for producing effective vaccines and has the major advantage of being simple and not requiring any special techniques for the purification and characterisation of recombinant proteins in the correct structure and conformation.
Indresh K. Srivastava, Manmohan Singh
openaire   +1 more source

Influenza DNA vaccines

Vaccine, 2002
DNA vaccines have been the subjects of much effort over the past decade due to their ability to induce broad-based immune responses and protection in various animal models of infectious and non-infectious diseases. In particular, influenza DNA vaccines have been well studied.
openaire   +2 more sources

DNA Vaccine Design

2006
The purpose of this chapter is to present basic strategies for the construction of DNA vaccines. This chapter discusses considerations relevant to the selection of a target gene, construction of a DNA expression vector for use as a vaccine, and molecular modifications of the vector to improve protein expression and to augment immunogenicity.
openaire   +2 more sources

DNA vaccination/genetic vaccination.

Current topics in microbiology and immunology, 1998
H, Koprowski, D B, Weiner
openaire   +3 more sources

[DNA vaccines].

Annales pharmaceutiques francaises, 2003
DNA vaccination is a new vaccine approach used to induce an immune response to an antigen protein expressed in vivo. It is based on the introduction, via intramuscular injections, particle bombardment, or nasal spray, of a purified DNA plasmid encoding for the polypeptide sequence.
openaire   +1 more source

Home - About - Disclaimer - Privacy